Merit Medical Systems (NASDAQ:MMSI) Raised to Strong-Buy at Wall Street Zen

Merit Medical Systems logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen upgraded Merit Medical Systems to “strong buy” from “buy.” The broader analyst consensus is “Moderate Buy,” with eight Buy ratings and five Hold ratings and an average price target of $105.91.
  • Merit Medical reported quarterly EPS of $1.12, beating the $1.04 consensus estimate, while revenue of $416.24 million also topped forecasts and rose 8.4% year over year.
  • Shares opened at $84.39, within a 52-week range of $59.74 to $94.85. Insider Brian Lloyd sold 16,722 shares under a pre-arranged trading plan.
  • MarketBeat previews top five stocks to own in December.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a research note issued to investors on Saturday, Wall Street Zen reports.

A number of other analysts have also recently issued reports on MMSI. JPMorgan Chase & Co. lifted their target price on shares of Merit Medical Systems from $95.00 to $110.00 and gave the company an "overweight" rating in a research note on Friday, October 30th. Canaccord Genuity Group increased their price target on shares of Merit Medical Systems from $94.00 to $121.00 and gave the stock a "buy" rating in a research note on Friday, October 30th. Freedom Capital assumed coverage on shares of Merit Medical Systems in a report on Tuesday, October 27th. They set a "hold" rating on the stock. Bank of America raised their price target on shares of Merit Medical Systems from $92.00 to $97.00 and gave the company a "neutral" rating in a report on Thursday, August 13th. Finally, Needham & Company LLC lifted their price objective on shares of Merit Medical Systems from $101.00 to $106.00 and gave the company a "buy" rating in a research note on Friday, October 30th. Eight equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $105.91.

Get Our Latest Stock Report on MMSI

Merit Medical Systems Stock Performance

Shares of MMSI stock opened at $84.39 on Friday. Merit Medical Systems has a fifty-two week low of $59.74 and a fifty-two week high of $94.85. The stock's 50-day moving average is $87.79 and its two-hundred day moving average is $77.51. The company has a debt-to-equity ratio of 0.42, a current ratio of 4.52 and a quick ratio of 3.05. The firm has a market cap of $5.06 billion, a P/E ratio of 22.20, a PEG ratio of 2.10 and a beta of 0.56.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last announced its quarterly earnings results on Thursday, October 29th. The medical instruments supplier reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.08. The business had revenue of $416.24 million during the quarter, compared to analyst estimates of $410.56 million. Merit Medical Systems had a return on equity of 14.12% and a net margin of 9.94%. The firm's revenue was up 8.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.92 EPS. Analysts predict that Merit Medical Systems will post 3.86 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Merit Medical Systems news, insider Brian Lloyd sold 16,722 shares of the company's stock in a transaction that occurred on Monday, November 16th. The stock was sold at an average price of $86.33, for a total transaction of $1,443,610.26. Following the completion of the sale, the insider owned 60,132 shares of the company's stock, valued at $5,191,195.56. This represents a 21.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.70% of the company's stock.

Institutional Trading of Merit Medical Systems

A number of institutional investors and hedge funds have recently modified their holdings of MMSI. Congress Asset Management Co. increased its stake in Merit Medical Systems by 6.4% during the third quarter. Congress Asset Management Co. now owns 1,260,675 shares of the medical instruments supplier's stock valued at $108,708,000 after acquiring an additional 76,338 shares during the period. Dimensional Fund Advisors LP raised its holdings in Merit Medical Systems by 1.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,237,298 shares of the medical instruments supplier's stock valued at $85,287,000 after acquiring an additional 12,285 shares in the last quarter. William Blair Investment Management LLC bought a new stake in shares of Merit Medical Systems in the 2nd quarter worth approximately $78,894,000. Maverick Capital Ltd. lifted its position in shares of Merit Medical Systems by 46.9% in the 1st quarter. Maverick Capital Ltd. now owns 714,081 shares of the medical instruments supplier's stock worth $49,222,000 after acquiring an additional 227,915 shares during the period. Finally, Boston Trust Walden Corp lifted its position in shares of Merit Medical Systems by 12.4% in the 3rd quarter. Boston Trust Walden Corp now owns 531,396 shares of the medical instruments supplier's stock worth $45,822,000 after acquiring an additional 58,540 shares during the period. 99.66% of the stock is currently owned by institutional investors and hedge funds.

Merit Medical Systems Company Profile

(Get Free Report)

Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy. The company's portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels. Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally.

Featured Articles

Analyst Recommendations for Merit Medical Systems (NASDAQ:MMSI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Merit Medical Systems Right Now?

Before you consider Merit Medical Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merit Medical Systems wasn't on the list.

While Merit Medical Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines